Integrated Diagnostics Holdings Plc IDHC
LSE · United Kingdom · Health Services
$0.5220-0.03 (-4.74%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
With U.S. Treasury yields at a 25 year high and income investors suddenly spoiled for choice, many large funds are shuffling capital toward government bonds and away from smaller companies. That creates an opening in under followed United Kingdom quality stocks that are not front and centre in broker research. This article walks through three such overlooked small caps from our high quality screener and explains why they may deserve a closer look. The three stocks covered below are just a...
UK government borrowing recently hit £18.3b for August, and rising financing costs are forcing Westminster to think harder about where every pound goes. That focus on discipline creates a sweet spot for smaller British companies that already run tight, efficient operations but still sit off the big fund radar. This article highlights three such underfollowed UK stocks with solid fundamentals from our high quality small cap screener. The three stocks below are just a sample from this tighter,...
UK gilt yields are sitting at multi decade highs, which keeps many investors parked in cash or large caps. That hesitation can leave smaller high quality British stocks with solid fundamentals trading quietly in the background. For patient investors willing to look beyond the headlines, that quiet can be an entry point. This article highlights three under followed UK stocks from our quality screen that merit a closer look. The three stocks below are just a first cut from our High Quality...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.